The editors wanted to introduce an interesting and varied topic of UC and would like to thank prominent researchers of bladder cancer around the world who participated in this topic.
Editorial on Urothelial Carcinoma
Current status of the focused series “Urothelial Carcinoma”
Review Articles on Urothelial Carcinoma
Role of immunotherapy in Bacillus Calmette-Guérin unresponsive: non-muscle invasive bladder cancer
Perioperative immunotherapy in muscle-invasive bladder cancer
Review of non-invasive urinary biomarkers in bladder cancer
Variant histology in bladder cancer: diagnostic and clinical implications
Neoadjuvant chemotherapy for upper tract urothelial carcinoma
Current perspectives on novel systemic therapeutic agents beyond immune checkpoint inhibition in metastatic urothelial carcinoma
Nephron-sparing approaches in the management of upper tract urothelial carcinoma: indications and clinical outcomes
The prognostic role of steroid hormone receptor signaling pathways in urothelial carcinoma
The therapeutic and prognostic implications of molecular biomarkers in urothelial carcinoma
Disclosure:
The focused issue “Urothelial Carcinoma” was commissioned by the editorial office, Translational Cancer Research without any sponsorship or funding. Ja Hyeon Ku and Hyung Suk Kim are serving as the unpaid Guest Editors for the focused issue.